Most recent by Jeffrey A. Sparks, MD, MMSc
Possible asthma phenotype associated with rheumatoid arthritis
A prospective chart review suggests a novel asthma phenotype associated with rheumatoid arthritis, with possible common causality, according to results published in The Journal of Allergy and Clinical Immunology: In Practice.
VIDEO: When, how to use remote monitoring to triage patients with rheumatoid arthritis
WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, spotlights a study evaluating the impact of remote monitoring of rheumatoid arthritis.
VIDEO: Screening may become an option in the future for ILD in rheumatoid arthritis
WASHINGTON — Healio spoke with Jeffrey A. Sparks, MD, MMSc, about baseline results from the SAIL-RA study, which assesses which patients with rheumatoid arthritis may be at risk for developing interstitial lung disease.
VIDEO: ‘Provocative’ observational study assesses DMARD use in RA-ILD
WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, highlights an observational study investigating the impact of disease-modifying antirheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.
VIDEO: Translational studies may ‘move the field forward’ in rheumatoid arthritis
WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, discusses two translational studies focused on human tissue for the treatment of rheumatoid arthritis.
VIDEO: Investigating phenotypes of rheumatoid arthritis-associated interstitial lung disease
SAN DIEGO — In this Healio video, Jeffrey A. Sparks, MD, MMSc, highlighted studies from members of his group at Brigham and Women’s Hospital that were presented at ACR Convergence 2023.
VIDEO: TNF inhibitors safe for RA-ILD, but ‘unlikely they have much efficacy’
SAN DIEGO — In this video, Jeffrey A. Sparks, MD, MMSc, spoke with Healio about the safety of TNF inhibitors compared with alternative targeted therapies for patients with rheumatoid arthritis-associated interstitial lung disease.
VIDEO: Administering medication through the lymphatic system for rheumatoid arthritis
SAN DIEGO — In this Healio video, Jeffrey A. Sparks, MD, MMSc, discusses results from a proof-of-concept study that assessed the efficacy of administering medication for rheumatoid arthritis into the peripheral lymphatic systems.
VIDEO: ‘Eye-opening’ results suggest low-dose prednisone associated with adverse events
SAN DIEGO — Jeffrey A. Sparks, MD, MMSc, spoke with Healio about two “high-impact” presentations from ACR Convergence 2023 that assessed dosing of prednisone for patients with rheumatoid arthritis.
VIDEO: ‘Practice affirming’ findings from split-dosing methotrexate study at ACR
SAN DIEGO — In this video, Healio spoke with Jeffrey A. Sparks, MD, MMSc, results from a study conducted in India assessing the efficacy of treating rheumatoid arthritis with split-doses of methotrexate.